Junbin Liao

1.4k total citations · 1 hit paper
19 papers, 1.0k citations indexed

About

Junbin Liao is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Junbin Liao has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Hepatology. Recurrent topics in Junbin Liao's work include RNA modifications and cancer (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Junbin Liao is often cited by papers focused on RNA modifications and cancer (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Junbin Liao collaborates with scholars based in China and United States. Junbin Liao's co-authors include Sui Peng, Lixia Xu, Shuibin Lin, Zihao Dai, Ming Kuang, Zhenwei Peng, Shenghua Zhu, Shuling Chen, Wanjie Zhu and Ming Kuang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Molecular Cell.

In The Last Decade

Junbin Liao

17 papers receiving 1.0k citations

Hit Papers

N7-Methylguanosine tRNA modification enhances oncogenic m... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junbin Liao China 15 703 404 216 142 114 19 1.0k
Tianhong Su China 15 418 0.6× 269 0.7× 171 0.8× 162 1.1× 99 0.9× 22 748
Lehang Lin China 14 627 0.9× 377 0.9× 165 0.8× 90 0.6× 128 1.1× 18 855
Maria O. Hernandez United States 5 528 0.8× 428 1.1× 378 1.8× 143 1.0× 189 1.7× 6 1.0k
Jin Zhu China 12 863 1.2× 734 1.8× 209 1.0× 77 0.5× 49 0.4× 19 1.1k
Ariel Ka-Man Chow Hong Kong 16 672 1.0× 440 1.1× 624 2.9× 76 0.5× 110 1.0× 27 1.2k
Jacinth Wing‐Sum Cheu Hong Kong 10 383 0.5× 287 0.7× 296 1.4× 133 0.9× 227 2.0× 14 829
Antonia Castilho Hong Kong 4 637 0.9× 433 1.1× 512 2.4× 192 1.4× 45 0.4× 4 999
Qiong Xue China 13 451 0.6× 309 0.8× 258 1.2× 207 1.5× 59 0.5× 22 872
Chu‐Bin Luo China 15 510 0.7× 451 1.1× 295 1.4× 102 0.7× 132 1.2× 26 972
Franziska Arlt Germany 7 519 0.7× 236 0.6× 301 1.4× 106 0.7× 115 1.0× 7 848

Countries citing papers authored by Junbin Liao

Since Specialization
Citations

This map shows the geographic impact of Junbin Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbin Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbin Liao more than expected).

Fields of papers citing papers by Junbin Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junbin Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbin Liao. The network helps show where Junbin Liao may publish in the future.

Co-authorship network of co-authors of Junbin Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Junbin Liao. A scholar is included among the top collaborators of Junbin Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junbin Liao. Junbin Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liao, Junbin, et al.. (2023). BMI1 Silencing Liposomes Suppress Postradiotherapy Cancer Stemness against Radioresistant Hepatocellular Carcinoma. ACS Nano. 17(23). 23405–23421. 29 indexed citations
2.
Tang, Yuhao, Meiyan Zhu, Shuping Li, et al.. (2023). Size‐Tunable Nanoregulator‐Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular Carcinoma. Advanced Healthcare Materials. 12(30). e2302013–e2302013. 15 indexed citations
3.
Dai, Zihao, Wanjie Zhu, Xinyue Zhang, et al.. (2023). METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression. Molecular Therapy. 31(11). 3225–3242. 30 indexed citations
4.
Tan, Jiehui, Man Shu, Junbin Liao, et al.. (2023). Identification and validation of a plasma metabolomics-based model for risk stratification of intrahepatic cholangiocarcinoma. Journal of Cancer Research and Clinical Oncology. 149(13). 12365–12377. 7 indexed citations
5.
Chen, Shuling, Junbin Liao, Zebin Chen, et al.. (2023). Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC. Hepatology. 79(4). 780–797. 33 indexed citations
6.
Huang, Manling, Jianting Long, Yi Zhao, et al.. (2022). METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma. Cancer Research. 83(1). 89–102. 138 indexed citations
7.
Liao, Junbin, Xin Yue, Meiyan Zhu, et al.. (2022). Methyltransferase 1 is required for nonhomologous end‐joining repair and renders hepatocellular carcinoma resistant to radiotherapy. Hepatology. 77(6). 1896–1910. 46 indexed citations
8.
Chen, Zebin, Shunli Shen, Wenxuan Xie, et al.. (2022). Comparison of clinical efficacy between LAPS and ALPPS in the treatment of hepatitis B virus-related hepatocellular carcinoma. Gastroenterology report. 11. goad060–goad060. 3 indexed citations
9.
Su, Tianhong, Manling Huang, Junbin Liao, et al.. (2021). Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6‐Methyladenosine mRNA Methylation‐Dependent Mechanism. Hepatology. 74(3). 1339–1356. 98 indexed citations
10.
Chen, Zhihang, Wanjie Zhu, Shenghua Zhu, et al.. (2021). METTL1 promotes hepatocarcinogenesis via m7G tRNA modification‐dependent translation control. SHILAP Revista de lepidopterología. 11(12). e661–e661. 134 indexed citations
11.
Dai, Zihao, Zongren Wang, Kai Lei, et al.. (2021). Irreversible electroporation induces CD8+ T cell immune response against post-ablation hepatocellular carcinoma growth. Cancer Letters. 503. 1–10. 62 indexed citations
12.
Dai, Zihao, Hai‐Ning Liu, Junbin Liao, et al.. (2021). N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression. Molecular Cell. 81(16). 3339–3355.e8. 201 indexed citations breakdown →
13.
Tang, Mimi, Qian Zhou, Mengqi Huang, et al.. (2021). Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI. European Radiology. 31(11). 8615–8627. 29 indexed citations
15.
Liao, Junbin, Huilin Jin, Shaoqiang Li, et al.. (2019). Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 454–454. 47 indexed citations
16.
Chen, Shuling, Mimi Tang, Qian Zhou, et al.. (2019). Nomogram Development and Validation to Predict Hepatocellular Carcinoma Tumor Behavior by Preoperative Gadoxetic Acid-Enhanced MRI. SSRN Electronic Journal. 1 indexed citations
17.
Tan, Li, Shuling Chen, Guangyan Wei, et al.. (2019). Sublethal heat treatment of hepatocellular carcinoma promotes intrahepatic metastasis and stemness in a VEGFR1-dependent manner. Cancer Letters. 460. 29–40. 55 indexed citations
18.
Huang, Linlin, Ertao Zhai, Shirong Cai, et al.. (2018). Stress-inducible Protein-1 promotes metastasis of gastric cancer via Wnt/β-catenin signaling pathway. Journal of Experimental & Clinical Cancer Research. 37(1). 6–6. 30 indexed citations
19.
Su, Tianhong, Junbin Liao, Zihao Dai, et al.. (2018). Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation. Oncogene. 37(26). 3514–3527. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026